AstraZeneca (Global Rights to Movantik) Overview

  • Status
  • Private

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

AstraZeneca (Global Rights to Movantik) General Information

Description

Global rights to Movantik excluding Europe, Canada and Israel.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 1 Francis Crick Avenue
  • Cambridge Biomedical Campus
  • Cambridge CB2 0AA
  • England, United Kingdom
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Corporate Office
  • 1 Francis Crick Avenue
  • Cambridge Biomedical Campus
  • Cambridge CB2 0AA
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AstraZeneca (Global Rights to Movantik) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AstraZeneca (Global Rights to Movantik)‘s full profile, request access.

Request a free trial

AstraZeneca (Global Rights to Movantik) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AstraZeneca (Global Rights to Movantik)‘s full profile, request access.

Request a free trial

AstraZeneca (Global Rights to Movantik) FAQs

  • Where is AstraZeneca (Global Rights to Movantik) headquartered?

    AstraZeneca (Global Rights to Movantik) is headquartered in Cambridge, United Kingdom.

  • What industry is AstraZeneca (Global Rights to Movantik) in?

    AstraZeneca (Global Rights to Movantik)’s primary industry is Buildings and Property.

  • Is AstraZeneca (Global Rights to Movantik) a private or public company?

    AstraZeneca (Global Rights to Movantik) is a Private company.

  • What is the current valuation of AstraZeneca (Global Rights to Movantik)?

    The current valuation of AstraZeneca (Global Rights to Movantik) is .

  • What is AstraZeneca (Global Rights to Movantik)’s current revenue?

    The current revenue for AstraZeneca (Global Rights to Movantik) is .

  • Who are AstraZeneca (Global Rights to Movantik)’s investors?

    HealthCare Royalty Partners has invested in AstraZeneca (Global Rights to Movantik).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »